Filing Details
Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event.
8k filedNASDAQ:INDV
Indivior Pharmaceuticals, Inc. (INDV) Reports Material Event to SEC
Filing Details Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) filed a Form 8-K with the Securities and Exchange Commission on August 03, 2026, disclosing a material event. Market…
Market Context
Indivior Pharmaceuticals, Inc.'s stock currently trades at $37.37 with a market capitalization of $4.5B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Indivior Pharmaceuticals, Inc.'s stock.
All SEC filings for Indivior Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View INDV Stock Page
Frequently Asked Questions
Where can I read INDV's SEC filings?
Browse all filings on our INDV SEC filings page.
What types of SEC filings does Indivior Pharmaceuticals, Inc. file?
Public companies like Indivior Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.